Revolution Medicines (RVMD) Research & Development (2019 - 2026)
Revolution Medicines' Research & Development was $394.92 million in Q2 2026, up 76.2% from $224.13 million a year earlier and up 14.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Research & Development was $1.3 billion through Jun 30, 2026, up 68.4% year-over-year; for FY2025, it was $987.33 million, up 66.7% from FY2024.
- Research & Development has now increased for seven consecutive years, with a five-year compound annual growth rate of 49.5% (FY2020 to FY2025).
- In earlier years, Research & Development was $592.23 million in FY2024 (+40.0%), $423.14 million in FY2023 (+67.2%), $253.07 million in FY2022 (+35.4%) and $186.95 million in FY2021 (+41.4%).
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q1 2019.
- Compared with a year earlier, Research & Development has increased for 26 straight quarters, with growth averaging 60.1% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 22.1% in Q1 2023 to 124.5% in Q4 2023.
- Per Business Quant data, RVMD's Research & Development in the three quarters before Q2 2026 was $343.97 million (Q1 2026), $294.94 million (Q4 2025) and $262.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 394.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 394.92 Mn |
| Mar 31, 2026 | 343.97 Mn |
| Dec 31, 2025 | 294.94 Mn |
| Sep 30, 2025 | 262.51 Mn |
| Jun 30, 2025 | 224.13 Mn |
| Mar 31, 2025 | 205.75 Mn |
| Dec 31, 2024 | 188.10 Mn |
| Sep 30, 2024 | 151.75 Mn |
| Jun 30, 2024 | 134.93 Mn |
| Mar 31, 2024 | 118.02 Mn |
| Dec 31, 2023 | 148.48 Mn |
| Sep 30, 2023 | 107.74 Mn |
| Jun 30, 2023 | 97.98 Mn |
| Mar 31, 2023 | 68.95 Mn |
| Dec 31, 2022 | 66.13 Mn |
| Sep 30, 2022 | 69.46 Mn |
| Jun 30, 2022 | 61.00 Mn |
| Mar 31, 2022 | 56.49 Mn |
| Dec 31, 2021 | 53.68 Mn |
| Sep 30, 2021 | 46.47 Mn |
API Access
Revolution Medicines Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();